| 1 |
Huang GY. Epidemiological situation of Kawasaki disease[J]. Chin J Pract Pediatr, 2006, 21(10):721-723.
|
| 2 |
Sodoh T, Kangawa K, Minamtno N, et al. Anatriuretic peptide in porcine brain [J]. Nature, 1988, 322(6159):78-81.
|
| 3 |
Hall C. Essential biochem is try and physiology of NT－pro－BNP[J]. Eur J Heart Fail, 2004, 6:257-260.
|
| 4 |
Wu AH, Smith A. Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure [J]. Eur J Heart Fail, 2004, 6:355-358.
|
| 5 |
Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B－type natriuretic peptide (BNP) testing [J]. Eur Heart J, 2003, 24(19):1710-1718.
|
| 6 |
Redfield MM, Rodeheffe RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: Impact of age and gender [J]. J Am Coll Cardiol, 2002, 40(5):976-982.
|
| 7 |
Groenning BA, Nilsson JC, Sondergaard L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations [J]. Eur J Heart Fail, 2001, 3(6):699-708.
|
| 8 |
Zhao R, Sun GY. Clinical significance of B－type natriuretic peptide in patients with heart failure and coronary artery disease [J]. Chin J Cardiovasc Med, 2004, 9(3):234-235.
|
| 9 |
Magga J, Mamila M, Mantymaa P, et al. Brain natriuretic peptide in plasma, atria and ventricles of vasopressin and phenylephrine－infused conscious rats [J]. Endocrinology, 1994, 134:2505.
|
| 10 |
Harada M, Saito Y, Kuwahara K, et al. Interaction of myocytes and non－myocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture [J]. J Cardiovasc Pharmacot, 1998, 31(suppl):357-359.
|
| 11 |
Xu L, Chen LY. Structure, receptors and the physiological role of the natriuretic peptide [J]. Prog Biochem Biophy, 2002, 29(5):780-781.
|
| 12 |
Levin ER, Gardner DG, Samson WK. Nalriuretic peptides [J]. N Engl J Med, 1998, 339:321-328.
|
| 13 |
Pan BS. Clinical application of cardiac markers [J]. Chin J Lab Med, 2005, 28(1):124-126.
|
| 14 |
Hu DY, Sun YH. Cardiac markers in clinic practice and its progress [J]. Chin J Cardiovasc Rev, 2005, 3(12):934-936.
|
| 15 |
Mueller T, Gegenhuber A, Poelz W, et al. Biochemical diagnosis of impaired left ventricular ejection fraction－comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and aminoterminal proBNP (NT－proBNP) [J]. Clin Chem Lab Med, 2004, 42(2):159-163.
|
| 16 |
Jiang X, Ni Y, Jiang Y, et al. Outbreak of infection caused by Enterobacter cloacae producing the novel VEB－3 beta－lactamase in China [J]. J Clin Microbiol, 2005, 43(2):826-831.
|
| 17 |
Karasawa K. Advances in the imaging of vascular complications and their impact [J]. Prog Pediatr Cardiol, 2004, 19(1):153-160.
|
| 18 |
Wang L, Lin Y, Su YZ, et al. Review and analysis of 283 cases of Kawasaki disease [J]. Chin J Pediatr, 2004, 42(8):609-612.
|
| 19 |
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on cadiovascular disease in the young, American Heart Association [J]. Circulation, 2004, 110:2747-2771.
|
| 20 |
Goto T, Takase H, Toriama T, et al. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure [J]. Heart, 2003, 89(11):1303-1307.
|
| 21 |
Kawamura T, Wago M, Kawa GH, et al.Plasma brain natriuretic peptide concent rations in patients with Kawasaki disease [J]. Pediatr Int, 2000, 42:241-248.
|
| 22 |
Kurotobi S, Kawakami N, Shimizu K, et al. Brain nat riuretic peptide as a hormonalmarker of vent ricular diastolic dysfunction in children with Kawasaki disease [J]. Pediatr Cardiol, 2005, 26:425-430.
|
| 23 |
Huang BZ, Wang DS. The changes and significance of brain natriuretic peptide in children with Kawasaki disease [J]. J Guangdong Med Coll, 2008, 6(3):288-289.
|
| 24 |
Zhong Q, Wu BQ, Wen FQ, et al. The changes of cardiac troponin Ⅰ in Kawasaki disease with coronary diseases [J]. J Appl Clin Pediatr, 2002, 17(3):215-216.
|
| 25 |
Wang WL, Sun YP, Zheng XC, et al. Serum levels of brain natriuretic peptide and cardiac troponin Ⅰ in children with Kawasaki disease [J]. Chin Pediatr Emerg Med, 2009, 16(5):433-434.
|
| 26 |
Zhang JL, Zhang Y, Gao J, et al. Brain natriuretic peptide and early diagnosis of Kawasaki disease [J]. Clin Med China, 2009, 25(4):436-437.
|
| 27 |
Takemura G, Fujiwara H, Takatsu Y, et al. Ventricular exp ression of atrial and brain natriuretic peptides in patients with myocarditis [J]. Int J Cardiol, 1995, 52(2):213-222.
|
| 28 |
Wang HW. Some problems about Kawasaki disease complicated with cardiovascular damage [J]. Chin J Pract Pediatr, 2006, 21(10):730-732.
|
| 29 |
Zhang QY, Du JB, Chen YQ, et al. Changes in plasma N－terminal pro－brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice [J]. Chin J Pediatr, 2006, 44(12):886-890.
|
| 30 |
Peng Q, Wu Q, Chen CH, et al. Value of serum soluble interleukin－2R, interleukin－6 and C－reactive protein in the early diagnosis of Kawasaki disease [J]. Chin J Pediatr, 2006, 8(3):208-210.
|
| 31 |
Kiyoshi T, Shizuo A. Toll2 like recep tors in innate immunity [J]. Int Immunol, 2005, 17(1):1-14.
|
| 32 |
Brogan PA, Shall V, Klein N, et al. Beta－restricted T cell adherence to endothelial cells: A mechanism for superantigen－dependent vascular injury [J]. Arthritis Rheum, 2004, 50(2):589-597.
|
| 33 |
Wu YR, Chen SB, Huang MR, et al. Diagnostic value of plasma concentration of pro－brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects [J]. Chin J Pediatr, 2005, 43(3):161-164.
|
| 34 |
Sun YP, Wang WL, Ma SC, et al. The changes of serum heart－type fatty acid－binding protein and its clinical significance in children with Kawasaki disease [J]. Chin J Pract Pediatr, 2007, 22(12):933-934.
|
| 35 |
Kurotobi S, Kawakami N, Shimizu K, et al. Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease [J]. Pediatr Cardiol, 2005, 26(4):425-430.
|